Carmen Feijoo‐Carnero

1.0k citations
11 papers · 855 indexed · h-index 10

Carmen Feijoo‐Carnero

11 papers receiving 846 citations

Peers

Carmen Feijoo‐Carnero
Comparison fields: 5 of 72
  • Immunology 517
  • Cancer Research 166
  • Oncology 208
  • Molecular Biology 407
  • Physiology 15
Replace Ryo Koyama‐Nasu with:
Ryo Koyama‐Nasu Japan
Thijs J. Hagenbeek Netherlands
Remi Adelaiye‐Ogala United States
Jonathan F. Anker United States
Gabriëla Wright United States
Swathi Ramakrishnan United States
Xiao-Ping Zhong United States
Sandrine Prost United Kingdom
Marion Schuierer Germany
James R. Hernandez United States
Carmen Feijoo‐Carnero relative to Ryo Koyama‐Nasu Japan Ryo Koyama‐Nasu's profile →
Citations per field
00.5×1.5×2.4×
Ryo Koyama‐Nasu · 1×
Citations per year

Countries citing papers authored by Carmen Feijoo‐Carnero

Since Specialization
Citations

This map shows the geographic impact of Carmen Feijoo‐Carnero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Feijoo‐Carnero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Feijoo‐Carnero more than expected).

Fields of papers citing papers by Carmen Feijoo‐Carnero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Feijoo‐Carnero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Feijoo‐Carnero. The network helps show where Carmen Feijoo‐Carnero may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carmen Feijoo‐Carnero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carmen Feijoo‐Carnero Line = papers co-authored together Carmen Feijoo‐Carnero links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 201429
2 201333
3 201219
4 2012465
5 20121
6 201185
7 201067
8 200983
9 200418
10 200421
11 200034

About Carmen Feijoo‐Carnero

Carmen Feijoo‐Carnero is a scholar working on Immunology, Pathology and Forensic Medicine and Cancer Research, having authored 11 papers that have together received 855 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers), Glycosylation and Glycoproteins Research (3 papers), Ubiquitin and proteasome pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Genetic factors in colorectal cancer (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Immunology (517 citations), Cancer Research (166 citations) and Oncology (208 citations). Carmen Feijoo‐Carnero has collaborated with scholars based in United Kingdom, Spain and Ireland. Frequent co-authors include Doreen A. Cantrell, Linda V. Sinclair, David K. Finlay, Julia Rolf, Andrey A. Panteleyev, Klaus Okkenhaug, Ella Rosenzweig, Jens Hukelmann, Marı́a N. Navarro and Nick Morrice. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026